Articles
As a pharmacist by trade, I have been an inventor and an entrepreneur my whole life. Long gone are the days of independent corner drug stores, but working in a drug store as a teenage girl inspired and shaped me in so many ways. Read More ›
On May 20, 2025, the FDA had a meeting of its Oncologic Drug Advisory Committee (ODAC). Read More ›
KEY WORDS: clinical trials, FDA, ODAC, oncology, regulatory
As an investor, it can be difficult to navigate the ups and downs of the market and understand what the movements mean for your portfolio— particularly when you’re seeing constant headlines on the topic. Read More ›
Clinical trial recruitment and retention remain challenges in the quest to bring innovative therapies to all patients in need. In oncology, therapies continue to evolve, yet researchers are frequently faced with low trial participation, particularly among minority groups. Read More ›
Encourage Your Patients to Participate!
A coalition of more than 40 health insurers recently announced plans for prior authorization reform. Read More ›
During a recent presentation at the Summit on Cancer Health Disparities 2025 in Seattle, WA, Hoifung Poon, PhD, General Manager at Microsoft Health Futures, said that artificial intelligence represents a powerful tool to help close long-standing gaps in cancer care. Read More ›
Recent headlines have been dominated by economic policy and market fluctuations, sending shockwaves through the stock market. Whether you’re decades from retirement, approaching it in the near term, or already drawing down your portfolio, now is a good time to revisit your plan—and remind yourself what you can control when the markets feel unpredictable. Read More ›
Originally intended to foster innovation, such as extended-release formulations or novel delivery systems, recent years have seen a surge in 505(b)(2) applications for minor changes, such as vial size. Read More ›
HemOnc.org aims to provide consistently structured, evidence-based, and up-to-date information that is not only clinically relevant but also immediately usable to everyone, including pharmacists, other healthcare providers, and patients. Read More ›
Nurses and navigators, especially those embedded in community programs, can help bridge the access gap by promoting education, building trust, and facilitating access early in the patient journey. Read More ›